Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	collagen-containing extracellular matrix	FBN1 VWF ADAMTS9 CLEC14A ADAMTS15 ADAMTS20 CD151 SRPX NPNT	3.59e-04	530	87	9	GO:0062023
GeneOntologyCellularComponent	extracellular matrix	FBN1 VWF ADAMTS9 CLEC14A ADAMTS15 ADAMTS20 CD151 SRPX FBN3 NPNT	3.93e-04	656	87	10	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	FBN1 VWF ADAMTS9 CLEC14A ADAMTS15 ADAMTS20 CD151 SRPX FBN3 NPNT	4.03e-04	658	87	10	GO:0030312
MousePheno	belted	ADAMTS20 KIT	6.37e-05	3	65	2	MP:0002671
MousePheno	abnormal melanoblast migration	ADAMTS20 KIT	6.37e-05	3	65	2	MP:0009784
MousePheno	abnormal melanoblast physiology	ADAMTS20 KIT	6.37e-05	3	65	2	MP:0030904
MousePheno	brachyphalangia	ZEB1 FBN1 GAS1	8.82e-05	19	65	3	MP:0002543
Domain	Pept_M12B_GON-ADAMTSs	ADAMTS9 ADAMTS20	2.30e-05	2	90	2	IPR012314
Domain	GON	ADAMTS9 ADAMTS20	2.30e-05	2	90	2	PF08685
Domain	GON	ADAMTS9 ADAMTS20	2.30e-05	2	90	2	PS51046
Domain	Peptidase_M12B_N	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	3.64e-05	39	90	4	IPR002870
Domain	Pep_M12B_propep	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	3.64e-05	39	90	4	PF01562
Domain	DISINTEGRIN_1	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	4.04e-05	40	90	4	PS00427
Domain	Reprolysin	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	4.04e-05	40	90	4	PF01421
Domain	ADAM_MEPRO	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	4.04e-05	40	90	4	PS50215
Domain	DISINTEGRIN_2	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	4.04e-05	40	90	4	PS50214
Domain	Peptidase_M12B	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	4.04e-05	40	90	4	IPR001590
Domain	Disintegrin_dom	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	4.45e-05	41	90	4	IPR001762
Domain	-	PIK3C2B PI4KB TRRAP	5.79e-05	16	90	3	1.10.1070.11
Domain	PI3Kc	PIK3C2B PI4KB TRRAP	5.79e-05	16	90	3	SM00146
Domain	FBN	FBN1 FBN3	6.87e-05	3	90	2	IPR011398
Domain	PI3/4_kinase_cat_dom	PIK3C2B PI4KB TRRAP	8.38e-05	18	90	3	IPR000403
Domain	PI3_PI4_kinase	PIK3C2B PI4KB TRRAP	8.38e-05	18	90	3	PF00454
Domain	PI3_4_KINASE_3	PIK3C2B PI4KB TRRAP	8.38e-05	18	90	3	PS50290
Domain	PI3_4_KINASE_1	PIK3C2B PI4KB TRRAP	8.38e-05	18	90	3	PS00915
Domain	PI3_4_KINASE_2	PIK3C2B PI4KB TRRAP	8.38e-05	18	90	3	PS00916
Domain	ASX_HYDROXYL	FBN1 CLEC14A ADGRE4P FBN3 NPNT	1.22e-04	100	90	5	PS00010
Domain	EGF_3	FBN1 TMEM8B CLEC14A ADAM18 ADGRE4P FBN3 NPNT	1.41e-04	235	90	7	PS50026
Domain	EGF-type_Asp/Asn_hydroxyl_site	FBN1 CLEC14A ADGRE4P FBN3 NPNT	1.60e-04	106	90	5	IPR000152
Domain	ADAM_spacer1	ADAMTS9 ADAMTS15 ADAMTS20	1.79e-04	23	90	3	IPR010294
Domain	ADAM_spacer1	ADAMTS9 ADAMTS15 ADAMTS20	1.79e-04	23	90	3	PF05986
Domain	Peptidase_M12B_ADAM-TS	ADAMTS9 ADAMTS15 ADAMTS20	2.04e-04	24	90	3	IPR013273
Domain	ARM-type_fold	RANBP17 CAND1 PIK3C2B NBEAL1 LRRK2 ASPM UTP20 TRRAP	2.31e-04	339	90	8	IPR016024
Domain	Ubiquitin-rel_dom	PCGF6 PIK3C2B FRMPD1 RAPGEF4 GRB10 ZFAND4	2.64e-04	184	90	6	IPR029071
Domain	TB	FBN1 FBN3	4.75e-04	7	90	2	PF00683
Domain	-	FBN1 FBN3	6.31e-04	8	90	2	3.90.290.10
Domain	MetalloPept_cat_dom	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	6.32e-04	81	90	4	IPR024079
Domain	-	ADAMTS9 ADAM18 ADAMTS15 ADAMTS20	6.32e-04	81	90	4	3.40.390.10
Domain	-	RANBP17 CAND1 LRRK2 ASPM UTP20 TRRAP	7.15e-04	222	90	6	1.25.10.10
Domain	EGF_CA	FBN1 ADGRE4P FBN3 NPNT	7.92e-04	86	90	4	PF07645
Domain	TB	FBN1 FBN3	8.09e-04	9	90	2	PS51364
Domain	TB_dom	FBN1 FBN3	8.09e-04	9	90	2	IPR017878
Domain	TPR-like_helical_dom	SPAG1 SEL1L3 BBS4 HELZ CDC27 TRRAP	9.19e-04	233	90	6	IPR011990
Domain	EGF	FBN1 TMEM8B CLEC14A ADGRE4P FBN3 NPNT	9.61e-04	235	90	6	SM00181
Domain	PIK_HELICAL	PIK3C2B PI4KB	1.01e-03	10	90	2	PS51545
Domain	PI_Kinase	PIK3C2B PI4KB	1.01e-03	10	90	2	IPR015433
Domain	PInositide-3_kin_accessory_dom	PIK3C2B PI4KB	1.01e-03	10	90	2	IPR001263
Domain	EGF-like_dom	FBN1 CLEC14A ADAM18 ADGRE4P FBN3 NPNT	1.29e-03	249	90	6	IPR000742
Domain	EGF_CA	FBN1 ADGRE4P FBN3 NPNT	1.34e-03	99	90	4	PS01187
Domain	EGF_1	FBN1 TMEM8B CLEC14A ADAM18 FBN3 NPNT	1.46e-03	255	90	6	PS00022
Domain	EGF-like_CS	FBN1 TMEM8B CLEC14A ADAM18 FBN3 NPNT	1.64e-03	261	90	6	IPR013032
Domain	EGF_2	FBN1 TMEM8B CLEC14A ADAM18 FBN3 NPNT	1.77e-03	265	90	6	PS01186
Domain	ARM-like	RANBP17 CAND1 LRRK2 ASPM UTP20 TRRAP	1.95e-03	270	90	6	IPR011989
Domain	TPR_8	SPAG1 BBS4 CDC27	2.13e-03	53	90	3	PF13181
Domain	PI3/4_kinase_CS	PIK3C2B PI4KB	2.31e-03	15	90	2	IPR018936
Domain	EGF-like_Ca-bd_dom	FBN1 ADGRE4P FBN3 NPNT	3.05e-03	124	90	4	IPR001881
Domain	-	SPAG1 SEL1L3 BBS4 HELZ TRRAP	3.27e-03	207	90	5	1.25.40.10
Domain	TSP_1	ADAMTS9 ADAMTS15 ADAMTS20	3.49e-03	63	90	3	PF00090
Domain	TSP1	ADAMTS9 ADAMTS15 ADAMTS20	3.81e-03	65	90	3	SM00209
Domain	TSP1_rpt	ADAMTS9 ADAMTS15 ADAMTS20	3.81e-03	65	90	3	IPR000884
Domain	TSP1	ADAMTS9 ADAMTS15 ADAMTS20	3.81e-03	65	90	3	PS50092
Pubmed	The secreted metalloprotease ADAMTS20 is required for melanoblast survival.	ADAMTS9 ADAMTS20 KIT	9.30e-07	8	90	3	18454205
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RANBP17 CAND1 PPP4C ABR TMEM8B FRMPD1 SEL1L3 GRB10 ANKRD17 L2HGDH PRKCE ZFHX3 TRRAP ANKH DNAH14	6.19e-06	1489	90	15	28611215
Pubmed	The role of mast cells in the development of skin fibrosis in tight-skin mutant mice.	FBN1 KIT	6.62e-06	2	90	2	7704626
Pubmed	Three novel mutations of the fibrillin-1 gene and ten single nucleotide polymorphisms of the fibrillin-3 gene in Marfan syndrome patients.	FBN1 FBN3	6.62e-06	2	90	2	15221638
Pubmed	Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1.	ADAMTS9 ADAMTS20	6.62e-06	2	90	2	12514189
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MAPRE3 ZNF836 SPAG1 LIMA1 SERINC1 PI4KB SMC6 ZBTB21 OBSL1 BBS4 HELZ CDC27 MELK FGD6	7.40e-06	1321	90	14	27173435
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	LIMA1 PIK3C2B PI4KB ZBTB21 GRB10 ANKRD17 HELZ PRKCE MELK FGD6 TAB3	1.41e-05	861	90	11	36931259
Pubmed	ADAMTS metalloproteases generate active versican fragments that regulate interdigital web regression.	ADAMTS9 ADAMTS15 ADAMTS20	1.85e-05	20	90	3	19922873
Pubmed	A role for the Ankyrin repeat containing protein Ankrd17 in Nod1- and Nod2-mediated inflammatory responses.	NOD1 ANKRD17	1.98e-05	3	90	2	23711367
Pubmed	Role for the adaptor protein Grb10 in the activation of Akt.	GRB10 KIT	1.98e-05	3	90	2	11809791
Pubmed	Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation.	PI4KB SPG11	1.98e-05	3	90	2	25365221
Pubmed	Strain-specific white-spotting patterns in laboratory mice.	ADAMTS20 KIT	1.98e-05	3	90	2	10614578
Pubmed	A new Adamts9 conditional mouse allele identifies its non-redundant role in interdigital web regression.	ADAMTS9 ADAMTS20	1.98e-05	3	90	2	24753090
Pubmed	Degradomic Identification of Membrane Type 1-Matrix Metalloproteinase as an ADAMTS9 and ADAMTS20 Substrate.	ADAMTS9 ADAMTS20	1.98e-05	3	90	2	37169079
Pubmed	Genes and microRNAs associated with mouse cleft palate: A systematic review and bioinformatics analysis.	ZEB1 ADAMTS9 ADAMTS20	3.70e-05	25	90	3	29475039
Pubmed	LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.	NOD1 LRRK2	3.96e-05	4	90	2	27830463
Pubmed	Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly.	FBN1 FBN3	3.96e-05	4	90	2	25034023
Pubmed	Golgi retention and oncogenic KIT signaling via PLCγ2-PKD2-PI4KIIIβ activation in gastrointestinal stromal tumor cells.	PI4KB KIT	3.96e-05	4	90	2	37616163
Pubmed	Biosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanase.	ADAMTS9 ADAMTS15	3.96e-05	4	90	2	24220035
Pubmed	Progressive ankylosis, a new skeletal mutation in the mouse.	ADAMTS20 ANKH	3.96e-05	4	90	2	7276519
Pubmed	ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndrome.	ADAMTS9 ADAMTS20	6.59e-05	5	90	2	31600785
Pubmed	Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells.	VWF KIT	6.59e-05	5	90	2	29298288
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEMA6C CAND1 SERINC1 ZBTB21 ANKRD17 SPG11 MELK ANKH	7.07e-05	529	90	8	14621295
Pubmed	C-peptide increases Na,K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells.	ZEB1 PRKCE	9.87e-05	6	90	2	22162761
Pubmed	SGT1 is essential for Nod1 activation.	NOD1 NLRP4	9.87e-05	6	90	2	17420470
Pubmed	A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses.	NOD1 NLRP4	9.87e-05	6	90	2	17435760
Pubmed	Genome-Wide Analysis in Brazilians Reveals Highly Differentiated Native American Genome Regions.	ADAMTS9 SMC6	1.38e-04	7	90	2	28100790
Pubmed	The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.	ADAMTS9 ADAMTS15	1.38e-04	7	90	2	15599946
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZBTB21 ASPM OBSL1 MTR ANKRD17 HELZ ZFHX3 FHL3 CDC27 TRRAP ALG13	1.45e-04	1116	90	11	31753913
Pubmed	Cooperation of two ADAMTS metalloproteases in closure of the mouse palate identifies a requirement for versican proteolysis in regulating palatal mesenchyme proliferation.	ADAMTS9 ADAMTS20	1.84e-04	8	90	2	21041365
Pubmed	Cloning, characterization, and genomic structure of the mouse Ikbkap gene.	ACTL7B MELK	1.84e-04	8	90	2	11747609
Pubmed	Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly.	FBN1 VWF	2.36e-04	9	90	2	12122015
Pubmed	Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2.	TRAF5 TAB3	2.36e-04	9	90	2	17384642
Pubmed	Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses.	NOD1 NLRP4	2.36e-04	9	90	2	15107016
Pubmed	A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.	TRAF5 TAB3	2.94e-04	10	90	2	18079694
Pubmed	Transcription is required for establishment of germline methylation marks at imprinted genes.	SEMA6C GRB10	2.94e-04	10	90	2	19136628
Pubmed	Isolation of novel mouse genes that were differentially expressed in W/W(V) mouse fundus.	UTP20 KIT	2.94e-04	10	90	2	15065000
Pubmed	Human transcription factor protein interaction networks.	PCGF6 LIMA1 ZEB1 FBN1 ZBTB21 MTR ANKRD17 HELZ ZFHX3 TRRAP TAB3 IKZF5	3.13e-04	1429	90	12	35140242
Pubmed	Two new cataract loci, Ccw and To3, and further mapping of the Npp and Opj cataracts in the mouse.	LIM2 KIT	3.59e-04	11	90	2	8812411
Pubmed	c-kit+ cells minimally contribute cardiomyocytes to the heart.	VWF KIT	3.59e-04	11	90	2	24805242
Pubmed	Hydrocephalus in mouse B3glct mutants is likely caused by defects in multiple B3GLCT substrates in ependymal cells and subcommissural organ.	ADAMTS9 ADAMTS20	3.59e-04	11	90	2	33909046
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	PCGF6 FRMPD1 ZBTB21 OBSL1 ANKRD17 UTP20 CDC27 TRRAP KIT	3.82e-04	857	90	9	25609649
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	PCGF6 PPP4C OBSL1 ANKRD17 CDC27	4.25e-04	242	90	5	34011540
Pubmed	Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics.	ADAMTS9 ADAMTS20	4.30e-04	12	90	2	25770910
Pubmed	Global gene expression analysis in fetal mouse ovaries with and without meiosis and comparison of selected genes with meiosis in the testis.	ANKRD17 TAB3	5.07e-04	13	90	2	17431699
Pubmed	Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart.	VWF KIT	5.07e-04	13	90	2	20558824
Pubmed	Hormad1 mutation disrupts synaptonemal complex formation, recombination, and chromosome segregation in mammalian meiosis.	HORMAD1 NLRP4	5.91e-04	14	90	2	21079677
Pubmed	Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia.	VWF KIT	5.91e-04	14	90	2	10981960
Pubmed	Impaired ADAMTS9 secretion: A potential mechanism for eye defects in Peters Plus Syndrome.	ADAMTS9 BBS4	5.91e-04	14	90	2	27687499
Pubmed	Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.	CDC27 TRRAP	6.80e-04	15	90	2	16510875
Pubmed	HORMAD1-dependent checkpoint/surveillance mechanism eliminates asynaptic oocytes.	KIT HORMAD1	6.80e-04	15	90	2	22530760
Pubmed	Transcription factors SOHLH1 and SOHLH2 coordinate oocyte differentiation without affecting meiosis I.	KIT HORMAD1	6.80e-04	15	90	2	28504655
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	FBN1 VWF SRPX NPNT	6.86e-04	153	90	4	25037231
Pubmed	Detailed comparative map of human chromosome 19q and related regions of the mouse genome.	LIM2 ZNF836 ZNF160	7.12e-04	67	90	3	8812484
Pubmed	Fibulin-1 is required during cardiac ventricular morphogenesis for versican cleavage, suppression of ErbB2 and Erk1/2 activation, and to attenuate trabecular cardiomyocyte proliferation.	ADAMTS9 ADAMTS20	8.78e-04	17	90	2	22183742
Pubmed	Genome-wide pleiotropy of osteoporosis-related phenotypes: the Framingham Study.	RAPGEF4 ANKRD17	8.78e-04	17	90	2	20200953
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	FBN1 VWF CLEC14A NPNT	9.50e-04	167	90	4	22159717
Pubmed	Ankrd17, an ubiquitously expressed ankyrin factor, is essential for the vascular integrity during embryogenesis.	VWF ANKRD17	9.86e-04	18	90	2	19619540
Pubmed	GATA-like protein-1 (GLP-1) is required for normal germ cell development during embryonic oogenesis.	ZGLP1 KIT	9.86e-04	18	90	2	21123517
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	ADAMTS9 ADAMTS15 ADAMTS20	9.89e-04	75	90	3	20637190
Pubmed	Engagement of the G3BP2-TRIM25 Interaction by Nucleocapsid Protein Suppresses the Type I Interferon Response in SARS-CoV-2-Infected Cells.	PIK3C2B THAP9 FBN3	1.03e-03	76	90	3	36560452
Pubmed	SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.	RPL30 FBN1 VWF CLEC14A	1.08e-03	173	90	4	23979707
Pubmed	Coordination of canonical and noncanonical Hedgehog signalling pathways mediated by WDR11 during primordial germ cell development.	GAS1 KIT	1.10e-03	19	90	2	37516749
Pubmed	R2TP/Prefoldin-like component RUVBL1/RUVBL2 directly interacts with ZNHIT2 to regulate assembly of U5 small nuclear ribonucleoprotein.	RPL30 SPAG1 OBSL1 TRRAP SHQ1	1.12e-03	300	90	5	28561026
Pubmed	Endothelial Smad4 restrains the transition to hematopoietic progenitors via suppression of ERK activation.	VWF KIT	1.22e-03	20	90	2	24553180
Pubmed	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	RAPGEF4 ABCC11	1.22e-03	20	90	2	25187374
Pubmed	Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.	PIK3C2B PRKCE	1.35e-03	21	90	2	9446795
Pubmed	Combinatorial CRISPR screen identifies fitness effects of gene paralogues.	RANBP17 ASPM GRB10 PRKCE	1.41e-03	186	90	4	33637726
Pubmed	Lipid signatures reflect the function of the murine primary placentation†.	VWF SLC27A6	1.48e-03	22	90	2	34850819
Pubmed	HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.	PIK3C2B PRKCE	1.48e-03	22	90	2	11154208
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	OBSL1 MTR HELZ CDC27 MELK	1.52e-03	322	90	5	39098523
Pubmed	Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis.	ADAMTS9 ADAMTS20	1.62e-03	23	90	2	30814516
Pubmed	ADAMTS9-Mediated Extracellular Matrix Dynamics Regulates Umbilical Cord Vascular Smooth Muscle Differentiation and Rotation.	ADAMTS9 ADAMTS20	1.62e-03	23	90	2	26027930
Pubmed	GATA6 Regulates Aortic Valve Remodeling, and Its Haploinsufficiency Leads to Right-Left Type Bicuspid Aortic Valve.	FBN1 ADAMTS9	1.62e-03	23	90	2	29567669
Pubmed	USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c.	PCGF6 ANKRD17 HELZ	1.67e-03	90	90	3	35654790
Pubmed	Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution.	ZEB1 ADAMTS9	1.76e-03	24	90	2	20935629
Pubmed	Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease.	RPL30 LRRK2	1.76e-03	24	90	2	24725412
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	PPP4C PIK3C2B RAPGEF4 L2HGDH SPG11 TRRAP	1.87e-03	497	90	6	36774506
Pubmed	Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy.	PIK3C2B PRKCE	1.91e-03	25	90	2	17632570
Pubmed	Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120.	PIK3C2B PRKCE	1.91e-03	25	90	2	15689238
Pubmed	A G-quadruplex DNA structure resolvase, RHAU, is essential for spermatogonia differentiation.	KIT HORMAD1	1.91e-03	25	90	2	25611385
Pubmed	ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress.	ZBTB21 CDC27	2.07e-03	26	90	2	34162889
Pubmed	miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors.	VWF KIT	2.07e-03	26	90	2	21708977
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	LIMA1 ASPM UTP20 CDC27	2.20e-03	210	90	4	16565220
Pubmed	Identification of differentially expressed genes in mouse spermatogenesis.	ZNF836 ZNF160	2.23e-03	27	90	2	14581517
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	TRAF5 NOD1 CAND1 CLEC14A SMC6 ASPM ANKRD17 HELZ SPG11 TRRAP	2.27e-03	1327	90	10	32694731
Pubmed	Centrosome-related genes, genetic variation, and risk of breast cancer.	ASPM BBS4 CDC27	2.39e-03	102	90	3	20508983
Pubmed	Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation.	GAS1 CDC27	2.57e-03	29	90	2	22898775
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS9 ADAMTS15 ADAMTS20	3.24e-05	19	60	3	50
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZEB1 ZFHX3	1.11e-03	15	60	2	529
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	RANBP17 PCGF6 EGLN3 ZGLP1 PIK3C2B MTR HELZ UTP20 KIT HORMAD1 MELK FGD6 NLRP4 TAB3 NPNT ALG13	3.24e-07	822	90	16	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500	RANBP17 PCGF6 MTR HELZ KIT HORMAD1 MELK FGD6 NLRP4 TAB3 ALG13	1.17e-06	406	90	11	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500	RANBP17 PCGF6 EGLN3 KIT HORMAD1 MELK NLRP4 TAB3 SHQ1 ALG13	5.51e-06	386	90	10	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500	RANBP17 PCGF6 EGLN3 MTR UTP20 KIT HORMAD1 MELK NLRP4 ALG13	5.64e-06	387	90	10	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	RANBP17 PCGF6 PLA2G4C MTR HELZ KIT HORMAD1 MELK FGD6 NLRP4 ZFAND4 TAB3 NPNT ALG13	8.70e-06	820	90	14	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000	RANBP17 PCGF6 EGLN3 MTR HELZ UTP20 KIT HORMAD1 MELK NLRP4 TAB3 SHQ1 ALG13	2.46e-05	781	90	13	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000	RANBP17 PCGF6 EGLN3 MTR HELZ UTP20 KIT HORMAD1 MELK NLRP4 TAB3 SHQ1 ALG13	3.11e-05	799	90	13	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000	ZEB1 CAND1 ZBTB21 ADAMTS15 ADAMTS20 SRPX CDC27 ZFAND4	4.84e-05	307	90	8	gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000	LIMA1 TRAF5 CAND1 VWF ABR CLEC14A SMC6 RAPGEF4 ADAMTS15 PRKCE TNKS2 KIT ZFAND4	5.02e-05	837	90	13	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1	TBC1D8 RANBP17 VWF SLC27A6 GRB10 PRKCE PRRG4 KIT ZFAND4	5.96e-05	409	90	9	GSM476663_500
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2	TBC1D8 RANBP17 VWF SLC27A6 GRB10 PRKCE PRRG4 KIT ZFAND4	7.57e-05	422	90	9	GSM399442_500
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	SEMA6C MAPRE3 SLC27A6 ADAMTS9 FRMPD1 RAPGEF4 SEL1L3 OBSL1 MTR PRKCE CD151 HMGCS2 TRRAP	8.73e-05	884	90	13	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#2_top-relative-expression-ranked_500	EGLN3 PIK3C2B KIT	9.27e-05	21	90	3	gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k2_500
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000	RANBP17 PCGF6 EGLN3 MTR UTP20 KIT HORMAD1 MELK NLRP4 TAB3 SHQ1 ALG13	1.31e-04	795	90	12	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlas	dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500	RANBP17 PCGF6 EGLN3 UTP20 KIT HORMAD1 MELK ALG13	1.97e-04	376	90	8	gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	RPL30 LIMA1 ADAMTS9 SERINC1 GAS1 MTR ZFHX3 FGD6 TAB3	2.00e-04	480	90	9	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K5
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500	PLA2G4C ADAMTS9 BBS4 HMGCS2 KIT HORMAD1 NLRP4 ALG13	2.07e-04	379	90	8	gudmap_developingGonad_P2_ovary_500
CoexpressionAtlas	ratio_EmbryoidBody-blastocyst_vs_EmbryoidBody-fibro_top-relative-expression-ranked_1000_k-means-cluster#4	SMC6 ADAMTS20 L2HGDH TNKS2 THAP9 ALG13	2.27e-04	203	90	6	ratio_EB-blastocyst_vs_EB-fibro_1000_K4
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500	RANBP17 KIT HORMAD1 MELK FGD6 ZFAND4 TAB3 ALG13	2.31e-04	385	90	8	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000	FRMPD1 OBSL1 MTR CD151 HMGCS2 TRRAP	2.33e-04	204	90	6	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k2_1000
CoexpressionAtlas	dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500	KIT MELK TAB3 ALG13	2.49e-04	72	90	4	gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500	RANBP17 MTR UTP20 KIT HORMAD1 NLRP4 SHQ1 ALG13	2.79e-04	396	90	8	gudmap_dev gonad_e13.5_M_GermCell_Oct_500
CoexpressionAtlas	kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000	PCGF6 FBN1 ABR SLC27A6 ADAMTS9 SEL1L3 ASPM MELK FGD6 ZFAND4 IKZF5	3.22e-04	749	90	11	gudmap_kidney_P3_CapMes_Crym_1000
CoexpressionAtlas	dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000	TBC1D8 SEMA6C SLC27A6 ADAMTS9 RAPGEF4 SEL1L3 OBSL1 PRKCE CD151 HMGCS2 TRRAP CLEC12B	3.34e-04	880	90	12	gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_200	RANBP17 KIT HORMAD1 TAB3 ALG13	4.07e-04	147	90	5	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_200
CoexpressionAtlas	Myeloid Cells, DC.8+.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-3	TBC1D8 LIMA1 LRRK2 KIT	5.14e-04	87	90	4	GSM538252_100
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_100	SLC27A6 ADAMTS9 SEL1L3 HMGCS2	5.36e-04	88	90	4	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_100
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_1000	ADAMTS9 HMGCS2 HORMAD1	6.03e-04	39	90	3	gudmap_developingGonad_e18.5_testes_1000_k1
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PLA2G4C PIK3C2B CLEC14A RAPGEF4 PRKCE KIT	2.23e-10	194	90	9	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PLA2G4C PIK3C2B CLEC14A RAPGEF4 PRKCE KIT	2.23e-10	194	90	9	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 FBN1 VWF ABR PIK3C2B CLEC14A RAPGEF4 SRPX	5.24e-09	191	90	8	b2c86cde341fe350143658c8a8a4a9edbce3f19b
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 PRKCE KIT	5.46e-09	192	90	8	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4 GRB10 KIT	5.46e-09	192	90	8	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 PRKCE KIT	5.46e-09	192	90	8	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 PRKCE KIT	5.69e-09	193	90	8	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 GRB10 PRKCE KIT	5.69e-09	193	90	8	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 PRKCE KIT	5.69e-09	193	90	8	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 PRKCE KIT	5.92e-09	194	90	8	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PIK3C2B RAPGEF4 GRB10 PRKCE KIT	5.92e-09	194	90	8	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 PRKCE KIT	5.92e-09	194	90	8	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 VWF PLA2G4C PIK3C2B ADAMTS9 CLEC14A RAPGEF4 GRB10	6.17e-09	195	90	8	56efeb58df19f357d7d5ce87348d4f196a595421
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZEB1 VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4 GRB10 SRPX	6.17e-09	195	90	8	023e3c97dd3696d74f002ff8da0c04d876c82aef
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EGLN3 ZEB1 VWF PLA2G4C CLEC14A RAPGEF4 SEL1L3 KIT	6.17e-09	195	90	8	3826bfafe85f8aa9a508202ceb2b02e81b090498
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ZEB1 VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4 SRPX	9.58e-08	184	90	7	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 VWF PLA2G4C PIK3C2B ADAMTS9 RAPGEF4 GRB10	9.94e-08	185	90	7	808d5e880069aff8866cd2c733b9fe568a37701f
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 PLA2G4C PIK3C2B CLEC14A RAPGEF4 PRKCE	1.07e-07	187	90	7	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 VWF PLA2G4C PIK3C2B CLEC14A RAPGEF4 KIT	1.07e-07	187	90	7	dffa8447c2f3fdacf39a7258c6b4e81a25245041
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	ZEB1 VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4 SRPX	1.11e-07	188	90	7	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 PLA2G4C PIK3C2B CLEC14A RAPGEF4 PRKCE	1.19e-07	190	90	7	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF PLA2G4C PIK3C2B RAPGEF4 PRKCE	1.23e-07	191	90	7	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 PRKCE KIT	1.33e-07	193	90	7	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 SEL1L3 KIT	1.33e-07	193	90	7	643f992dbce639e7d147924d8b8f455fcebf215a
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 GRB10 SRPX	1.33e-07	193	90	7	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 SEL1L3 KIT	1.33e-07	193	90	7	01c71aa48875b5ad6c50cc810a72862e72f26ad0
ToppCell	IPF-Endothelial-VE_Venous\|IPF / Disease state, Lineage and Cell class	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 GRB10 SRPX	1.33e-07	193	90	7	29a655fa80feaabe846c90a28363b037e22d24ae
ToppCell	Endothelial-endothelial_cell_of_vein\|World / Lineage, Cell type, age group and donor	EGLN3 ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 SRPX	1.37e-07	194	90	7	3cbd9622a68e89add90e589867d88c83c5a33476
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EGLN3 VWF PLA2G4C CLEC14A RAPGEF4 SEL1L3 KIT	1.37e-07	194	90	7	32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 SEL1L3 KIT	1.37e-07	194	90	7	53a5e8863d79a052dff0758f389be5ac3883c721
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 FBN1 VWF ABR PIK3C2B CLEC14A RAPGEF4	1.37e-07	194	90	7	b0c15e7e4bcf30856fb628dedd7ba82df33489f5
ToppCell	Endothelial-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	ZEB1 VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4 SRPX	1.42e-07	195	90	7	c3a0aa34b672c99cb3a2a4e9218412dbd19da3ca
ToppCell	PCW_10-12-Endothelial-Endothelial_mature\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EGLN3 ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 KIT	1.47e-07	196	90	7	481d79bdaec069ad2746a28d39eeee8d3edf7305
ToppCell	Fetal_29-31_weeks-Endothelial\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EGLN3 ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 KIT	1.47e-07	196	90	7	3981f6c7487598f4f7ce4650ac0ac5bd41481d66
ToppCell	COVID-19-lung-Capillary_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 VWF SLC27A6 PIK3C2B CLEC14A RAPGEF4 PRKCE	1.58e-07	198	90	7	45419f2804b4be79bae6632e71c54e1af482d115
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	ZEB1 VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4 SRPX	1.58e-07	198	90	7	531b0f88c95f813e3914c96749f591e80ca321d0
ToppCell	Control-Endothelial_cells-Systemic_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 GRB10	1.37e-06	172	90	6	c55dce1ed3ed7312394b4e050e1de852a994e130
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 PLA2G4C ABR RAPGEF4 GRB10 FDXACB1	1.56e-06	176	90	6	dc5a22f9d1347f157bdd93e6e5769b983deccf1a
ToppCell	390C-Endothelial_cells-Endothelial-E-\|390C / Donor, Lineage, Cell class and subclass (all cells)	VWF ADAMTS9 CLEC14A RAPGEF4 GRB10 PRKCE	1.67e-06	178	90	6	804ac3725c1f88e2212172bfb9aa01d97a735621
ToppCell	Endothelial-A-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	SEMA6C ZEB1 VWF CLEC14A RAPGEF4 SRPX	1.67e-06	178	90	6	2f2602b9305d55f25afa9861dd6c6347ae179337
ToppCell	390C-Endothelial_cells-Endothelial-E\|390C / Donor, Lineage, Cell class and subclass (all cells)	VWF ADAMTS9 CLEC14A RAPGEF4 GRB10 PRKCE	1.67e-06	178	90	6	ad6dc4a375664c919bd48c35c48a561fc5a7de8c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 VWF PIK3C2B CLEC14A RAPGEF4 GRB10	1.72e-06	179	90	6	8f9e538c822940785130297712b75131812a4603
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 ADAMTS9 RAPGEF4 GRB10 ZNF160 KIT	1.78e-06	180	90	6	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	LIMA1 TRAF5 ZEB1 SLC27A6 FHL3 KIT	1.84e-06	181	90	6	7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a
ToppCell	Endothelial-A-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	MAPRE3 ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4	1.96e-06	183	90	6	2c3f2c25c38f0598b4787d2ec335efe00fdc9751
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 SRPX	1.96e-06	183	90	6	c1297d8eddfc7132e84ceef14f01b6281f9d0f6a
ToppCell	COPD-Endothelial-VE_Venous\|COPD / Disease state, Lineage and Cell class	VWF ADAMTS9 CLEC14A RAPGEF4 GRB10 SRPX	2.02e-06	184	90	6	44d716e7ba46a1ed03f5992631289653f8fd7d5e
ToppCell	Endothelial-A-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 SRPX	2.08e-06	185	90	6	ae49c61f6ecf128fe2a958b8c75c83688da75f59
ToppCell	COPD-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 GRB10	2.08e-06	185	90	6	4abe04198ab5047c211f8d09cdb9650fa52a3cd6
ToppCell	Endothelial-A-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 SRPX	2.15e-06	186	90	6	796cbae2a417502aaf0891fc9c382bbfd88967fe
ToppCell	COPD-Endothelial-VE_Peribronchial\|COPD / Disease state, Lineage and Cell class	VWF ADAMTS9 CLEC14A RAPGEF4 GRB10 SRPX	2.15e-06	186	90	6	23c7d0e8372a71546d687278b985f761d282f92f
ToppCell	Healthy-multiplets\|Healthy / disease group, cell group and cell class	EGLN3 LIMA1 CLEC14A ASPM KIT MELK	2.15e-06	186	90	6	2ec999b97e95afb898f8083042b0f188d3d234bc
ToppCell	COPD-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	VWF PIK3C2B ADAMTS9 CLEC14A GRB10 SRPX	2.22e-06	187	90	6	be42ee71d3412bb1f52593d8814de85c354a0efa
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175\|Adult / Lineage, Cell type, age group and donor	ZEB1 VWF PIK3C2B RAPGEF4 PRKCE KIT	2.22e-06	187	90	6	f3548817f2fded5978137bb252cb628ac199e4f6
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 PLA2G4C CLEC14A RAPGEF4 PRKCE	2.29e-06	188	90	6	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	ZEB1 VWF PIK3C2B ADAMTS9 RAPGEF4 SRPX	2.29e-06	188	90	6	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	Endothelial-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 SRPX	2.29e-06	188	90	6	0824d567356d360fd8e78e840c30529c139f98a1
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	LIMA1 ZEB1 VWF PIK3C2B CLEC14A SRPX	2.36e-06	189	90	6	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	Endothelial-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	ZEB1 VWF ADAMTS9 CLEC14A GRB10 SRPX	2.36e-06	189	90	6	04b565855f58ca0f343904d04be657b66e109076
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 VWF ABR PIK3C2B CLEC14A RAPGEF4	2.36e-06	189	90	6	6463890d8dbee4bc198f91628a5f784970de786a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 VWF ABR PIK3C2B CLEC14A RAPGEF4	2.43e-06	190	90	6	bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZEB1 VWF PIK3C2B ADAMTS9 RAPGEF4 SRPX	2.43e-06	190	90	6	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	COVID-19-lung-Artery_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LIMA1 ZEB1 VWF PIK3C2B RAPGEF4 SRPX	2.43e-06	190	90	6	07b675befcd1d0a9c90cb17b5d22323468325d51
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LIMA1 ZEB1 VWF PIK3C2B CLEC14A SRPX	2.43e-06	190	90	6	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ZEB1 VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4	2.43e-06	190	90	6	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EGLN3 VWF PIK3C2B CLEC14A SEL1L3 KIT	2.43e-06	190	90	6	7ba2be2630183df86de21689289a8620a4cd507e
ToppCell	Endothelial-A-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ZEB1 FBN1 VWF ADAMTS9 CLEC14A SRPX	2.51e-06	191	90	6	f702dfe88a9b04091dae87df61b2b4f43525f86a
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LIMA1 ZEB1 VWF PIK3C2B CLEC14A SRPX	2.51e-06	191	90	6	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBN1 GAS1 ADAMTS15 HMGCS2 SRPX NPNT	2.51e-06	191	90	6	cd497abed9e00e4e0becd9dbc036c6e7a60ae791
ToppCell	Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|World / Lineage, Cell type, age group and donor	RANBP17 NBEAL1 LRRK2 FBN3 DNAH14 NPNT	2.51e-06	191	90	6	d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TBC1D8 ZEB1 PIK3C2B ADAMTS9 RAPGEF4 GRB10	2.58e-06	192	90	6	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 FBN1 VWF PIK3C2B CLEC14A RAPGEF4	2.58e-06	192	90	6	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 PLA2G4C CLEC14A RAPGEF4 PRKCE	2.58e-06	192	90	6	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4	2.58e-06	192	90	6	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 GRB10	2.58e-06	192	90	6	c3dda7c48732b0b8bde36de282d64192f5e9b98f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 VWF ABR PIK3C2B CLEC14A RAPGEF4	2.58e-06	192	90	6	28eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EGLN3 VWF PLA2G4C CLEC14A SEL1L3 KIT	2.66e-06	193	90	6	d338a7c0585b69947c37f44aa0381619493e31ea
ToppCell	COPD-Endothelial-VE_Arterial\|COPD / Disease state, Lineage and Cell class	VWF PIK3C2B ADAMTS9 CLEC14A GRB10 SRPX	2.66e-06	193	90	6	1c701b6ab5f0f0239634adac94fa1c92bf3c36f4
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 VWF PIK3C2B CLEC14A RAPGEF4 KIT	2.66e-06	193	90	6	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ZEB1 VWF PIK3C2B ADAMTS9 RAPGEF4 KIT	2.66e-06	193	90	6	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	COPD-Endothelial\|COPD / Disease state, Lineage and Cell class	VWF ADAMTS9 CLEC14A RAPGEF4 GRB10 SRPX	2.66e-06	193	90	6	093b28dcccb5841c995d0b33fae0efd6b88f97e0
ToppCell	Control-Endothelial-VE_Arterial\|World / Disease state, Lineage and Cell class	VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4 SRPX	2.66e-06	193	90	6	52c0f2c7af57436f23e0c0e0c87086c47695e2c4
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 ZEB1 PLA2G4C CLEC14A RAPGEF4 PRKCE	2.66e-06	193	90	6	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 FBN1 VWF ABR PIK3C2B CLEC14A	2.66e-06	193	90	6	0b328f725f6feba263783eaca60c142e80df90f3
ToppCell	IPF-Endothelial-VE_Venous\|World / Disease state, Lineage and Cell class	VWF ADAMTS9 CLEC14A RAPGEF4 GRB10 SRPX	2.66e-06	193	90	6	ef66a46e7ab44fcc4005a23416e6da478a4cce37
ToppCell	IPF-Endothelial\|IPF / Disease state, Lineage and Cell class	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 GRB10	2.74e-06	194	90	6	9591993aa2dcba3d09a0f1ea8b8f2439c26482d6
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBN1 GAS1 ADAMTS15 GRB10 SRPX NPNT	2.74e-06	194	90	6	d47e3c7b22444aef0c7a37bc8cd8853b590a56dd
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 SRPX	2.74e-06	194	90	6	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	Control-Endothelial\|Control / Disease state, Lineage and Cell class	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 SRPX	2.74e-06	194	90	6	485fe5538fabec457b9a51feb641f2a91cbf4e18
ToppCell	LAM-Endothelial\|LAM / Condition, Lineage and Cell class	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 SRPX	2.74e-06	194	90	6	1241e3e75414b619abc9431627619f5c194ec930
ToppCell	Control-Endothelial-VE_Arterial\|Control / Disease state, Lineage and Cell class	VWF PIK3C2B ADAMTS9 CLEC14A RAPGEF4 SRPX	2.82e-06	195	90	6	56c66a3655820961e1390b8f4bcc5618e8d0c5a8
ToppCell	IPF-Endothelial-VE_Peribronchial\|IPF / Disease state, Lineage and Cell class	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 GRB10	2.82e-06	195	90	6	2c3ad3cb79f11119ac69c413a938d21199145040
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 SRPX	2.82e-06	195	90	6	81a98ebb0d43f416f9a8bba580531dc0cfea8f74
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 FBN1 VWF ABR PIK3C2B CLEC14A	2.82e-06	195	90	6	77e47d2e8b3eb7f7c9620369ccaf87581f923bdb
ToppCell	ASK428-Endothelial-Endothelium\|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq	ZEB1 VWF ADAMTS9 CLEC14A RAPGEF4 SRPX	2.91e-06	196	90	6	b1a81eddb91fb462360692b7b0a3ba4a947eac40
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZEB1 VWF ABR PIK3C2B CLEC14A RAPGEF4	2.91e-06	196	90	6	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 KIT	2.91e-06	196	90	6	2a2a93b89dcb98043cb1f8b422ac8c55e2edc37b
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EGLN3 VWF ADAMTS9 CLEC14A RAPGEF4 SRPX	2.91e-06	196	90	6	5609b2d93172a488b35d854298a3a4e504e17e28
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EGLN3 LIMA1 ZEB1 VWF PIK3C2B CLEC14A	2.91e-06	196	90	6	cf7f384c1771274e766bab03ecc3dfbd13f2df60
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	EGLN3 ZEB1 VWF CLEC14A RAPGEF4 KIT	2.91e-06	196	90	6	29ed8b1c4cd730db8632fde6eece404f1883a86d
Disease	2-hydroxyglutaric acid measurement	EGLN3 ADAMTS15 L2HGDH	2.20e-06	9	89	3	EFO_0010446
Disease	connective tissue disease (implicated_via_orthology)	FBN1 FBN3	2.69e-05	3	89	2	DOID:65 (implicated_via_orthology)
Disease	cortical surface area measurement	MAPRE3 PCGF6 FBN1 ABR SLC27A6 ADAMTS9 NBEAL1 TMEM8B GAS1 ADAMTS20 ZFHX3 KIT FGD6 FBN3	4.85e-05	1345	89	14	EFO_0010736
Disease	Ovarian Mucinous Adenocarcinoma	LRRK2 TRRAP MELK	1.12e-04	31	89	3	C1335167
Disease	mesangial proliferative glomerulonephritis (biomarker_via_orthology)	FBN1 VWF	2.49e-04	8	89	2	DOID:4783 (biomarker_via_orthology)
Disease	visual epilepsy (is_implicated_in)	ASPM L2HGDH	4.86e-04	11	89	2	DOID:11832 (is_implicated_in)
Disease	susceptibility to chronic sinus infection measurement	CAND1 ADGRE4P NLRP4	1.15e-03	68	89	3	EFO_0008419
Disease	coagulation factor measurement	VWF ASPM	1.65e-03	20	89	2	EFO_0004634
Disease	Disproportionate short stature	FBN1 OBSL1 ANKH	1.65e-03	77	89	3	C0878659
Disease	HIV-1 infection, Susceptibility to viral and mycobacterial infections	ADAM18 FRMPD1	1.82e-03	21	89	2	EFO_0000180, Orphanet_391311
Disease	venous thromboembolism, plasminogen activator inhibitor 1 measurement	VWF ZNF160	1.82e-03	21	89	2	EFO_0004286, EFO_0004792
Disease	Ovarian Serous Adenocarcinoma	LRRK2 TRRAP	2.18e-03	23	89	2	C1335177
Disease	venous thromboembolism, tissue plasminogen activator measurement	VWF ZNF160	2.18e-03	23	89	2	EFO_0004286, EFO_0004791
Disease	Neoplasm of the genitourinary tract	ZFHX3 KIT	2.38e-03	24	89	2	cv:C0042065
Disease	corneal resistance factor	ACTL7B RANBP17 FBN1 ADAMTS15 ADAMTS20 CDC27	2.46e-03	451	89	6	EFO_0010067
Disease	neutrophil percentage of leukocytes	TBC1D8 MAPRE3 LIM2 FBN1 HELZ KIT HORMAD1	2.49e-03	610	89	7	EFO_0007990
Disease	FEV change measurement, response to zileuton	GRB10 PRKCE	2.58e-03	25	89	2	EFO_0005921, EFO_0007676
Disease	level of Sterol ester (27:1/18:2) in blood serum	ZGLP1 ANKRD17	2.79e-03	26	89	2	OBA_2045194

Protein segments in the cluster

Peptide	Gene	Start	Entry
GSQSLRILCYEKCYD	ABR	561	Q12979
YVAAISCLKRANYLA	BBS4	286	Q96RK4
AVIIDLGSQYCKCGY	ACTL7B	51	Q9Y614
RQYYLGDKCQVCLES	ALG13	491	Q9NP73
YALNGRLCKLGTAYC	ADAM18	476	Q9Y3Q7
RLCKLGTAYCYNGQC	ADAM18	481	Q9Y3Q7
SLYRFLGNKSSYDCC	DEPDC4	156	Q8N2C3
GGYICSCLVKYTLFN	ADGRE4P	76	Q86SQ3
LCLACSAGYYELAQV	ANKRD17	271	O75179
LRGSYRCVCNLGYEA	FBN3	701	Q75N90
GDGRCITCIYYLNKN	EGLN3	141	Q9H6Z9
VKKAATCLQAAYRGY	ASPM	1801	Q8IZT6
CKLICRANGTGYFYV	ADAMTS15	616	Q8TE58
KDRCKLYCQVAGTNY	ADAMTS20	651	P59510
YYTAKACKNSICLDL	NBEAL1	831	Q6ZS30
SICYSALKSALCGNY	RANBP17	831	Q9H2T7
KDYHLQTCCGSLAYA	MELK	161	Q14680
SIGCLLARNQYYRKS	PPDPFL	6	Q8WWR9
VLYCQAKDRGLYVCA	OBSL1	306	O75147
CLGNKCYLQTDSIAY	LIM2	46	P55344
GCTCKLYAIRTQEYS	LRP10	461	Q7Z4F1
RCSYCNNKLSLGTYA	LIMA1	416	Q9UHB6
EYCCYGDLLNFLRRK	KIT	671	P10721
SSFARCYNIRGSYKC	NPNT	226	Q6UXI9
KLCVQGAALLYEYCQ	L2HGDH	111	Q9H9P8
LSYLYKENNAAICRC	MTMR8	191	Q96EF0
ALARKHPYLTQLYCC	PRKCE	461	Q02156
YYSIAKCVAALTRAC	CAND1	796	Q86VP6
KLSIQCYLRALDRCY	HMGCS2	256	P54868
GAYDKARYLQVLHCC	ABCC11	596	Q96J66
AARGICANYLKLTYC	NOD1	671	Q9Y239
IIAKIADYGIAQYCC	LRRK2	2011	Q5S007
YLTYCGKVFNGLRCT	GAS1	186	P54826
LVVSAYCLKYCSSLR	NLRP4	586	Q96MN2
YTLCKRFLEQGICRY	HELZ	181	P42694
RTFDGKLKCRYCNYA	IKZF5	76	Q9H5V7
RVGCYYCLFQNEKLL	C17orf75	121	Q9HAS0
YQYLLAALLCCCGKG	PIK3C2B	971	O00750
AGLYYPKDSARSCCL	PLA2G4C	526	Q9UP65
CKLFCRVAGNTAYYQ	ADAMTS9	686	Q9P2N4
DCAKCNESLYGRKYI	FHL3	6	Q13643
NLRGTYKCICNSGYE	FBN1	741	P35555
NSAKDLACLIAGYYR	FRMPD1	476	Q5SYB0
ALVRCTTLCLGYYKN	ANKH	201	Q9HCJ1
TCATLACYLTDNKLY	DNAH14	2021	Q0VDD8
NYTKIEQLCSGAAYC	MAPRE3	31	Q9UPY8
YVCLRRSGLYCSTKG	GRB10	311	Q13322
CAYGTRYLDDLCVKI	HORMAD1	51	Q86X24
CGTVCLKYLLFTYNC	CD151	11	P48509
LCYRLTYQTCDKALT	FDXACB1	586	Q9BRP7
KGYLALCSYNCKEAI	CDC27	471	P30260
NTLQKYYCRVRGGRC	DEFB103A	26	P81534
YILCSICKGYLIDAT	PCGF6	131	Q9BYE7
TDLYYQRLALCGCKG	UTP20	606	O75691
CLCGYYENLEKGITL	RAPGEF4	56	Q8WZA2
LLHYCKANLCGILYF	SEL1L3	296	Q68CR1
ACCRALSQESSKYLY	TAB3	41	Q8N5C8
KCTTAYVLCYPNAGL	MTR	276	Q99707
AALQYCCGFADLKYC	SHISAL2B	31	A6NKW6
YLLDKRACRQVCYSL	SHQ1	261	Q6PI26
YYKTALGTRCDIRCQ	SRPX	76	P78539
SCAGYCLVCYLLQVK	PI4KB	656	Q9UBF8
CNILVGYKAVYRLCF	SERINC1	81	Q9NRX5
SRCGYRLCARAYLNG	TRAF5	436	O00463
RCHLRANGYLCKYQF	CLEC14A	161	Q86T13
GCAYFQKGNIYISRC	CLEC12B	241	Q2HXU8
HGKNYCRQVLCLYDL	SPG11	1986	Q96JI7
NLRSRAKGAYICTYC	ZBTB21	661	Q9ULJ3
KCNECGKVFRYNSYL	ZNF160	426	Q9HCG1
YCSYLLAGGCQKRSF	VWF	56	P04275
LGTACGKYYRVCTLA	RPL30	81	P62888
ICYAGYVANKLSALL	THAP9	716	Q9H5L6
YYGNLVEESLGKCCL	TBC1D8	531	O95759
ECAIYTNRALCYLKL	SPAG1	656	Q07617
VCQACSSNKYGLDYL	FGD6	1251	Q6ZV73
CKECGKYFRYNSLLI	ZNF620	226	Q6ZNG0
CKLYFDNLLSQRAYC	SMC6	941	Q96SB8
CAVRGKLTDECYNYI	SEMA6C	111	Q9H3T2
FGLLGYYLCITKCNR	PRRG4	131	Q9BZD6
CKLLRTHNYLYAACE	TMEM8B	196	A6NDV4
AYCGHLQTCRLLLSY	TNKS2	441	Q9H2K2
FSQLLTCPYCDRGYK	ZEB1	166	P37275
YCLNDYNISEGCTLK	ZFAND4	81	Q86XD8
TVFQYIGELCRYLCK	SLC27A6	306	Q9Y2P4
NYCYRCGNVAAILEL	PPP4C	261	P60510
DSYYSKALGGLLLCC	UGT2A1	231	P0DTE4
LCNACGIRYKKYGTR	ZGLP1	226	P0C6A0
LAYCLLNYCKRNYGD	TRRAP	1696	Q9Y4A5
NECGKVFSYYSCLAR	ZNF836	641	Q6ZNA1
GDSYQCKLCRYNTQL	ZFHX3	981	Q15911
CSLCGKAFYKRYRLT	ZNF649	236	Q9BS31